Create free account

ORX Orexo AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · orexo.com

13.40SEK0.00%Mkt Cap: 45.02M $P/E: —Today

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products in…

Industry Peers

Drug Manufacturers - Specialty & Generic

$64.30BUSDP/E 25.0

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

$28.27BUSDP/E 12.1

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

Viatris Inc. - Common Stock

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

Neurocrine Biosciences, Inc. - Common Stock

$14.55BUSDP/E 21.0

$12.60BUSDP/E 22.8

Elanco Animal Health Incorporated Common Stock

Dr. Reddy's Laboratories Ltd Common Stock

$10.20BUSDP/E 29.2

$8.50BUSDP/E 18.4

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

Hims & Hers Health, Inc. Class A Common Stock

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Headline	Source	Time
Older
Orexo meddelar att FDA har godkänt bolagets Investigational New Drug (IND)-ansökan för OX640 för behandling av anafylaxi	Aktiellt	Sep 14
Orexo AB (ORXOY) Q2 2026 Earnings Call Highlights: Strategic Advances Amidst Legal and ... Orexo AB (ORXOY) showcases R&D progress and strategic collaborations while navigating legal hurdles and financial restructuring.	GuruFocus.com	Jul 16